Literature DB >> 24981346

GSK's darapladib failures dim hopes for anti-inflammatory heart drugs.

Asher Mullard.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24981346     DOI： 10.1038/nrd4381

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  9 in total

1.  Cardiovascular pathobiology of inflammasomes: inflammatory machinery and beyond.

Authors:  Pin-Lan Li
Journal:  Antioxid Redox Signal       Date:  2015-04-01       Impact factor: 8.401

Review 2.  Lipoprotein-associated phospholipase A2: The story continues.

Authors:  Fubao Huang; Kai Wang; Jianhua Shen
Journal:  Med Res Rev       Date:  2019-05-29       Impact factor: 12.944

Review 3.  Redox regulation of NLRP3 inflammasomes: ROS as trigger or effector?

Authors:  Justine M Abais; Min Xia; Yang Zhang; Krishna M Boini; Pin-Lan Li
Journal:  Antioxid Redox Signal       Date:  2015-01-19       Impact factor: 8.401

Review 4.  Biomarkers of plaque instability.

Authors:  P K Shah
Journal:  Curr Cardiol Rep       Date:  2014-12       Impact factor: 2.931

Review 5.  Macroalgal Proteins: A Review.

Authors:  Ronan O' Brien; Maria Hayes; Gary Sheldrake; Brijesh Tiwari; Pamela Walsh
Journal:  Foods       Date:  2022-02-16

6.  Unraveling the PAF-AH/Lp-PLA2 controversy.

Authors:  Diana M Stafforini; Guy A Zimmerman
Journal:  J Lipid Res       Date:  2014-07-09       Impact factor: 5.922

Review 7.  Novel biomarkers for cardiovascular risk prediction.

Authors:  Juan Wang; Guo-Juan Tan; Li-Na Han; Yong-Yi Bai; Miao He; Hong-Bin Liu
Journal:  J Geriatr Cardiol       Date:  2017-02       Impact factor: 3.327

8.  Lp-PLA2 inhibition prevents Ang II-induced cardiac inflammation and fibrosis by blocking macrophage NLRP3 inflammasome activation.

Authors:  Si-Lin Lv; Zi-Fan Zeng; Wen-Qiang Gan; Wei-Qi Wang; Tie-Gang Li; Yu-Fang Hou; Zheng Yan; Ri-Xin Zhang; Min Yang
Journal:  Acta Pharmacol Sin       Date:  2021-07-05       Impact factor: 6.150

Review 9.  pCRP-mCRP Dissociation Mechanisms as Potential Targets for the Development of Small-Molecule Anti-Inflammatory Chemotherapeutics.

Authors:  Vittorio Caprio; Lina Badimon; Mario Di Napoli; Wen-Hui Fang; Glenn R Ferris; Baoqiang Guo; Rocco S Iemma; Donghui Liu; Yasmin Zeinolabediny; Mark Slevin
Journal:  Front Immunol       Date:  2018-05-28       Impact factor: 7.561
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.